Thomas Scientific is once again expanding the breadth of its product portfolio after a new strategic distribution partnership agreement with Agilent Technologies. The partnership is another significant step forward for Thomas Scientific as it continues to accelerate growth within the molecular biology and diagnostics markets. Agilent offers one of the broadest molecular biology portfolios of any company serving the life science market. The partnership agreement will provide Thomas Scientific's customers with access to more than 700 bioreagent products – including qPCR instruments, reagents, PCR enzymes, and other molecular biology reagents.